SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-023004
Filing Date
2023-02-03
Accepted
2023-02-02 19:08:01
Documents
12
Period of Report
2023-02-02
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d435190d8k.htm   iXBRL 8-K 29875
  Complete submission text file 0001193125-23-023004.txt   154552

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fdmt-20230202.xsd EX-101.SCH 2897
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fdmt-20230202_lab.xml EX-101.LAB 17977
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fdmt-20230202_pre.xml EX-101.PRE 11289
6 EXTRACTED XBRL INSTANCE DOCUMENT d435190d8k_htm.xml XML 3360
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39782 | Film No.: 23583028
SIC: 2836 Biological Products, (No Diagnostic Substances)